MENU
+Compare
AZN
Stock ticker: NASDAQ
AS OF
Oct 16, 04:59 PM (EDT)
Price
$83.84
Change
-$0.99 (-1.17%)
Capitalization
261.1B

AZN AstraZeneca PLC Forecast, Technical & Fundamental Analysis

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999... Show more

AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AZN with price predictions
Oct 15, 2025

AZN in downward trend: price may decline as a result of having broken its higher Bollinger Band on October 01, 2025

AZN broke above its upper Bollinger Band on October 01, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 48 similar instances where the stock broke above the upper band. In of the 48 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for AZN moved out of overbought territory on October 09, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AZN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 01, 2025. You may want to consider a long position or call options on AZN as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AZN just turned positive on October 01, 2025. Looking at past instances where AZN's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

AZN moved above its 50-day moving average on October 01, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for AZN crossed bullishly above the 50-day moving average on October 03, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AZN advanced for three days, in of 352 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 283 cases where AZN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.882) is normal, around the industry mean (9.662). P/E Ratio (31.951) is within average values for comparable stocks, (24.491). Projected Growth (PEG Ratio) (0.976) is also within normal values, averaging (2.055). Dividend Yield (0.018) settles around the average of (0.028) among similar stocks. P/S Ratio (4.693) is also within normal values, averaging (3.576).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AZN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AZN is expected to report earnings to fall 47.00% to $1.15 per share on November 06

AstraZeneca PLC AZN Stock Earnings Reports
Q3'25
Est.
$1.15
Q2'25
Beat
by $1.08
Q1'25
Beat
by $1.39
Q4'24
Beat
by $1.03
Q3'24
Beat
by $1.06
The last earnings report on July 29 showed earnings per share of $2.17, beating the estimate of $1.09. With 4.32M shares outstanding, the current market capitalization sits at 261.10B.
A.I.Advisor
published Dividends

AZN paid dividends on September 08, 2025

AstraZeneca PLC AZN Stock Dividends
А dividend of $0.51 per share was paid with a record date of September 08, 2025, and an ex-dividend date of August 08, 2025. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1 Francis Crick Avenue
Phone
+44 2037495000
Employees
89900
Web
https://www.astrazeneca.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SMHX39.040.70
+1.83%
VanEck Fabless Semiconductor ETF
IVE206.490.85
+0.41%
iShares S&P 500 Value ETF
FFC16.710.03
+0.18%
Flaherty & Crumrine Preferred and Income Securities Fund
UJAN42.070.05
+0.11%
Innovator US Equity Ultra Buff ETF™ Jan
PSCJ29.440.02
+0.05%
Pacer Swan SOS Conservative (July) ETF

AZN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AZN has been loosely correlated with GSK. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if AZN jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZN
1D Price
Change %
AZN100%
-0.34%
GSK - AZN
65%
Loosely correlated
-0.84%
NVS - AZN
62%
Loosely correlated
-0.22%
SNY - AZN
53%
Loosely correlated
-0.57%
BIIB - AZN
48%
Loosely correlated
-1.14%
AZNCF - AZN
48%
Loosely correlated
-0.61%
More